Expression and purification of the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPARα)

Protein Expression and Purification

Volumn 62, Issue 2, 2008, Pages 185-189

  Müller, Mathias Q ^a   Roth, Christian ^b   Sträter, Norbert ^b   Sinz, Andrea ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Ligand binding domain; Mass spectrometry; PPAR ; Purification

Indexed keywords

ESCHERICHIA COLI PROTEIN; HYBRID PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PPAR ALPHA; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ESCHERICHIA COLI;

EID: 54049093931     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.07.016     Document Type: Article

References (16)

1. Michalik L., and Wahli W. Peroxisome proliferator activated receptors: three isoforms for a multitude of functions. Curr. Opin. Biotech. 10 (1999) 564-570
2. Plutzky J. The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis. Am. J. Cardiol. 92 (2003) 34J-41J
3. Evans R.M., Barish G.D., and Wang Y.X. PPARs and the complex journey to obesity. Nat. Med. 10 (2004) 355-361
4. Issemann I., Prince R.A., Tugwood J.D., and Green S. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol. 11 (1993) 37-47
5. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
6. Qi C., Zhu Y., and Reddy J.K. Peroxisome proliferator-activated receptors, coactivators, and downstream targets. Cell. Biochem. Biophys. 32 (2000) 187-204
7. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
8. He T.C., Chan T.A., Vogelstein B., and Kinzler K.W. PPARδ is an APC-regulated target of nonsteroidal antiinflammatory drugs. Cell 99 (1999) 335-345
9. Lim H., Gupta R.A., Ma W., Paria C., Moller D.E., Morrow J.D., DuBois R.N., Trzaskos J.M., and Dey S.K. Cyclooxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev. 13 (1999) 1561-1574
10. Chaturvedi R.K., and Beal M.F. PPAR: a therapeutic target in Parkinson's disease. J. Neurochem. 106 (2008) 506-518
11. Letavernier E., Perez J., Joye E., Bellocq A., Fouqueray B., Haymann J.-P., Heudes D., Wahli W., Desvergne B., and Baud L. Peroxisome proliferator-activated receptor β/δ exerts a strong protection from ischemic acute renal failure. J. Am. Soc. Nephrol. 16 (2005) 2395-2402
12. Issemann I., Prince R.A., Tugwood J.D., and Green S. The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol. 11 (1993) 37-47
13. Berger J.P., Akiyama T.E., and Meinke P.T. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol. Sci. 26 (2005) 244-251 (and references cited herein)
14. Cronet P., Petersen J.F.W., Folmer R., Blomberg N., Sjöblom K., Karlsson U., Lindstedt E.-L., and Bamberg K. Structure of the PPARα and -γ ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure 9 (2001) 699-706
15. Xu H.E., Lambert M.H., Montana V.G., Plunket K.D., Moore L.B., Collins J.L., Oplinger J.A., Kliewer S.A., Gampe R.T., McKee D.D., Moore J.T., and Willson T.M. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 98 (2001) 13919-13924
16. Schulz D.M., Kalkhof S., Schmidt A., Ihling C., Stingl C., Mechtler K., Zschörnig O., and Sinz A. Annexin A2/p11 interaction: new insights into annexin A2 tetramer structure by chemical cross-linking, high-resolution mass spectrometry, and computational modeling. Proteins 69 (2007) 254-269